Table 6.
Univariate analysis of factors affecting the therapeutic effect
| Unelevated serum albumin levels (n=89) | Elevated serum albumin levels (n=200) | t/χ2 | P | |
|---|---|---|---|---|
| Age | ||||
| ≤65 years | 57 | 82 | 13.103 | <0.001 | 
| >65 years | 32 | 118 | ||
| Gender | ||||
| Male | 45 | 124 | 3.319 | 0.0685 | 
| Female | 44 | 76 | ||
| Treatment methods | ||||
| Shu Fu Pai® Protein Short Peptides Beverage | 43 | 94 | 0.423 | 0.836 | 
| Intravenous human albumin | 46 | 106 | ||
| Body mass index | 22.5±1.4 | 22.8±1.6 | 0.678 | 0.754 | 
| Comorbidities | ||||
| Hypertension | 10 | 22 | 0.335 | 0.772 | 
| Diabetes | 8 | 12 | 0.442 | 0.663 | 
| Type of disease | ||||
| Tumors | 50 | 66 | 13.773 | <0.001 | 
| Abnormal liver function indicators | 68 | 115 | 6.771 | 0.010 | 
| Pre-treatment albumin levels | ||||
| <20 g/L | 67 | 110 | 10.673 | <0.001 | 
| >20 g/L | 22 | 90 | 
Note: χ2: data from Chi-square test; t: data from t-test.